Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Скринер
Новости
О нас

HYPR - Hyperfine, Inc. Последние новости | Finranks

Home

/

HYPR

H

Hyperfine, Inc. (HYPR)

NGM – Цена в реальном времени. Валюта: USD

1.47

-0.22 (-13.02%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

1.55

+0.08 (5.44%)

После закрытия: Jun 26, 2026, 7:54 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings.

Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript

Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript

Hyperfine, Inc. (HYPR) Q1 2026 Earnings Call Transcript

Hyperfine Q1 Earnings Call Highlights

Hyperfine Q1 Earnings Call Highlights

Hyperfine NASDAQ: HYPR reported a sharp year-over-year increase in first-quarter revenue and reiterated its full-year 2026 outlook, as management pointed to continued adoption of its next-generation Swoop portable MRI system across hospitals, neurology offices and international markets.

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates

Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.09 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.12 per share a year ago.

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update. “Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating.

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to present at the upcoming 2026 Jefferies Global Healthcare Conference on Thursday, June 4th at 8:45 am Eastern Time (ET). A live audio webcast and an archive of the recording will be available through the Investors page of Hyperfine, Inc.'s c.

Видео

No Data

There is no data to display

Пресс-релизы

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

GUILFORD, Conn.--(BUSINESS WIRE)--PRIME study results show bedside portable MRI cut order-to-scan time vs conventional MRI and identified critical ED findings.

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced first quarter 2026 financial results and provided a business update. “Our execution in Q1 was strong. We delivered our second-highest revenue quarter to date with over 80% year-over-year revenue growth, driven by our accelerating.

Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution

Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution

NEW DELHI--(BUSINESS WIRE)--AIIMS New Delhi has begun clinical use of the Swoop® system, becoming the first hospital in India to deploy bedside MRI.

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

GUILFORD, Conn.--(BUSINESS WIRE)--Next-gen Swoop system and latest Optive AI software receive CE & UKCA marks, bringing Hyperfine's most advanced portable MRI tech to European markets.